IDR 246.0
(2.5%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 582.25 Billion IDR | -23.84% |
2022 | 764.55 Billion IDR | -7.16% |
2021 | 823.52 Billion IDR | 66.99% |
2020 | 493.15 Billion IDR | 7.88% |
2019 | 457.12 Billion IDR | 14.9% |
2018 | 397.84 Billion IDR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 194.58 Billion IDR | 20.09% |
2024 Q2 | 140.92 Billion IDR | -27.58% |
2024 Q3 | 140.73 Billion IDR | -0.13% |
2023 Q3 | 177.15 Billion IDR | 15.31% |
2023 FY | 582.25 Billion IDR | -23.84% |
2023 Q4 | 162.02 Billion IDR | -8.54% |
2023 Q2 | 153.62 Billion IDR | -15.31% |
2023 Q1 | 181.39 Billion IDR | -3.7% |
2022 Q2 | 216.75 Billion IDR | 33.93% |
2022 Q1 | 161.84 Billion IDR | -7.28% |
2022 FY | 764.55 Billion IDR | -7.16% |
2022 Q4 | 188.36 Billion IDR | -4.67% |
2022 Q3 | 197.58 Billion IDR | -8.84% |
2021 Q2 | 228.09 Billion IDR | 1.35% |
2021 Q4 | 174.55 Billion IDR | -10.86% |
2021 Q3 | 195.81 Billion IDR | -14.15% |
2021 Q1 | 225.05 Billion IDR | 49.34% |
2021 FY | 823.52 Billion IDR | 66.99% |
2020 FY | 493.15 Billion IDR | 7.88% |
2020 Q1 | 88.78 Billion IDR | 0.0% |
2020 Q4 | 150.69 Billion IDR | 12.56% |
2020 Q3 | 133.87 Billion IDR | 50.79% |
2020 Q2 | 88.78 Billion IDR | 0.0% |
2019 FY | 457.12 Billion IDR | 14.9% |
2018 FY | 397.84 Billion IDR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
PT Metro Healthcare Indonesia Tbk | 89.65 Billion IDR | -549.449% |
PT Medikaloka Hermina Tbk | 1824.23 Billion IDR | 68.082% |
PT Mitra Keluarga Karyasehat Tbk | 1968.05 Billion IDR | 70.414% |
PT Murni Sadar Tbk | 167.6 Billion IDR | -247.4% |
PT Famon Awal Bros Sedaya Tbk | 515.99 Billion IDR | -12.843% |
PT Royal Prima Tbk | 75.23 Billion IDR | -673.906% |
PT Kedoya Adyaraya Tbk | 128.11 Billion IDR | -354.491% |
PT Sarana Meditama Metropolitan Tbk | 434.04 Billion IDR | -34.148% |
PT Siloam International Hospitals Tbk | 3644.9 Billion IDR | 84.025% |
PT Sejahteraraya Anugrahjaya Tbk | 718.02 Billion IDR | 18.908% |